Socially Significant Diseases: Modern Approaches to Prevention and Therapy

Experts discussed modern approaches to the prevention and treatment of socially significant diseases as part of the business programme of the 5^th ‘Ensuring Drug Security’ Russian Pharmaceutical Forum, which took place on 18 June 2025 on the opening day of the St. Petersburg International Economic Forum.

The timely prevention and treatment of major chronic non-communicable diseases play a key role in preserving human capital. In 2025, Russia launched a new national project called ‘Long and Active Life’ with a key focus on reducing the prevalence of chronic non-communicable diseases in an effort to ensure accelerated growth in people’s healthy life expectancy. As part of the national project, federal projects are being implemented to combat socially significant cardiovascular and oncological diseases, diabetes, and Hepatitis C. Cardiovascular and respiratory diseases account for the bulk of deaths from non-communicable diseases due to their high prevalence. Considering the significant contribution of these diseases to the overall mortality level, their negative impact on the healthy life expectancy of the working-age population, and related GDP losses, adopting additional measures to prevent, diagnose, organize medical care, and improve drug supplies would be an important step towards improving the health of the nation and ensuring its sustainable development.

“The battle against socially significant diseases should begin with prevention, the promotion of a healthy lifestyle, and the dissemination of a culture based on health preservation. To achieve the goals of the national project ‘Long and Active Life’, it is crucial to solve the problem of the prevalence of cardiovascular and respiratory diseases, as well as the introduction of additional programmes to help patients with chronic non-communicable diseases,” said Yury Zhulev, President of the Russian Hemophilia Society and Co-Chairman of the Russian Patients Association.

Experts discussed what measures need to be introduced into practical healthcare in order to realize the potential of new federal projects and extend the working capacity of patients with the most common chronic non-communicable diseases, primarily with diseases that involve high blood pressure and diseases of the respiratory system, what progressive therapeutic solutions are changing the paradigm of care for patients with chronic non-communicable diseases, what solutions could sway the system of medical care for such patients towards prevention and the early detection of diseases in order to significantly reduce the burden of severe disabling diseases and achieve accelerated growth in the number of people leading a healthy lifestyle.

The full programme of the event is available on the official website of the 5^th ‘Ensuring Drug Security’ Russian Pharmaceutical Forum.